Matthew Taylor

Stock Analyst at Jefferies

(3.23)
# 1,017
Out of 4,650 analysts
178
Total ratings
58.72%
Success rate
8.58%
Average return

Stocks Rated by Matthew Taylor

Abbott Laboratories
Oct 17, 2024
Maintains: Hold
Price Target: $120$125
Current: $114.07
Upside: +9.58%
Edwards Lifesciences
Sep 18, 2024
Downgrades: Hold
Price Target: $85$70
Current: $68.52
Upside: +2.16%
Insulet
Aug 9, 2024
Maintains: Neutral
Price Target: $211$223
Current: $233.37
Upside: -4.44%
InMode
Jul 23, 2024
Downgrades: Hold
Price Target: $21$19
Current: $17.98
Upside: +5.67%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75$76
Current: $90.60
Upside: -16.11%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $5
Current: $0.75
Upside: +563.04%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107$121
Current: $140.71
Upside: -14.01%
Orchestra BioMed Holdings
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $5.87
Upside: +138.50%
GE HealthCare Technologies
Nov 30, 2023
Initiates: Hold
Price Target: $80
Current: $85.93
Upside: -6.90%
Tandem Diabetes Care
Oct 2, 2023
Maintains: Buy
Price Target: $47$45
Current: $32.75
Upside: +37.40%
Initiates: Underperform
Price Target: $0.5
Current: $0.34
Upside: +45.01%
Upgrades: Buy
Price Target: $58$53
Current: $19.32
Upside: +174.33%
Maintains: Hold
Price Target: $22$24
Current: $13.15
Upside: +82.51%
Maintains: Buy
Price Target: $320$345
Current: $356.01
Upside: -3.09%
Upgrades: Hold
Price Target: $115$130
Current: $103.60
Upside: +25.48%
Initiates: Buy
Price Target: $230
Current: $208.74
Upside: +10.18%
Initiates: Buy
Price Target: $20
Current: $12.27
Upside: +63.00%
Initiates: Hold
Price Target: $75
Current: $70.24
Upside: +6.78%
Initiates: Hold
Price Target: $85
Current: $63.76
Upside: +33.31%
Initiates: Buy
Price Target: $75
Current: $74.20
Upside: +1.08%
Initiates: Hold
Price Target: $245
Current: $246.83
Upside: -0.74%
Initiates: Buy
Price Target: $88
Current: $42.56
Upside: +106.77%
Initiates: Hold
Price Target: $62
Current: $36.01
Upside: +72.17%
Initiates: Hold
Price Target: $210
Current: $236.63
Upside: -11.25%
Initiates: Buy
Price Target: $12
Current: $5.27
Upside: +127.70%
Initiates: Buy
Price Target: $125
Current: $72.10
Upside: +73.37%
Initiates: Buy
Price Target: $50
Current: $84.76
Upside: -41.01%
Initiates: Hold
Price Target: $210
Current: $510.88
Upside: -58.89%
Initiates: Underperform
Price Target: $31
Current: $4.91
Upside: +531.36%
Upgrades: Buy
Price Target: $96
Current: $53.16
Upside: +80.59%
Initiates: Neutral
Price Target: $7
Current: $1.89
Upside: +270.37%
Upgrades: Overweight
Price Target: $266
Current: $238.91
Upside: +11.34%
Maintains: Equal-Weight
Price Target: $17$16
Current: $6.75
Upside: +137.04%